Patents by Inventor Gordon King

Gordon King has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240241960
    Abstract: Various systems and methods are described for implementing remote attestation and data provenance verification. An example method for attestation and provenance verification, performed by a computing node, includes: receiving evidence from a client relating to a computing task; analyzing the evidence to determine a provenance verification result for trustworthiness of the computing task; evaluating compliance of the computing task with a policy; and returning an attestation token that includes the provenance verification result for the computing task, in response to determining the computing task is compliant with the policy.
    Type: Application
    Filed: March 29, 2024
    Publication date: July 18, 2024
    Inventors: Gordon King, Kent Thompson, Mingshen Sun, Shih-Han Wang, Yanhui Zhao, Eunjung Yoon, Haidong Xia
  • Patent number: 11526448
    Abstract: An apparatus is described. The apparatus includes a memory controller to interface with a multi-level memory, where, an upper level of the multi-level memory is to act as a cache for a lower level of the multi-level memory. The memory controller has circuitry to determine: i) an original address of a slot in the upper level of memory from an address of a memory request in a direct mapped fashion; ii) a miss in the cache for the request because the slot is pinned with data from another address that competes with the address; iii) a partner slot of the slot in the cache in response to the miss; iv) whether there is a hit or miss in the partner slot in the cache for the request.
    Type: Grant
    Filed: September 27, 2019
    Date of Patent: December 13, 2022
    Assignee: Intel Corporation
    Inventors: Zhe Wang, Alaa R. Alameldeen, Yi Zou, Gordon King
  • Publication number: 20200026655
    Abstract: An apparatus is described. The apparatus includes a memory controller to interface with a multi-level memory, where, an upper level of the multi-level memory is to act as a cache for a lower level of the multi-level memory. The memory controller has circuitry to determine: i) an original address of a slot in the upper level of memory from an address of a memory request in a direct mapped fashion; ii) a miss in the cache for the request because the slot is pinned with data from another address that competes with the address; iii) a partner slot of the slot in the cache in response to the miss; iv) whether there is a hit or miss in the partner slot in the cache for the request.
    Type: Application
    Filed: September 27, 2019
    Publication date: January 23, 2020
    Inventors: Zhe WANG, Alaa R. Alameldeen, Yi Zou, Gordon King
  • Patent number: 10202447
    Abstract: The invention relates inter alia to a bivalent, bispecific construct comprising an anti-IL-6 antibody, or derivative thereof, and an anti-IL-23 antibody, or derivative thereof and its use in therapy. The invention also relates to useful anti-IL-6 antibodies and anti-IL-23 antibodies.
    Type: Grant
    Filed: October 19, 2015
    Date of Patent: February 12, 2019
    Assignee: MedImmune Limited
    Inventors: Kenneth Grabstein, William Brady, Gordon King, Natalie Winblade Nairn, Kurt David Shanebeck, Paul Heffner Slagle, Kenneth Christopher Thornton, Michael Peter Vanbrunt, Andrea Wang, Hengyu Xu
  • Publication number: 20160194391
    Abstract: The invention relates inter alia to a bivalent, bispecific construct comprising an anti-IL-6 antibody, or derivative thereof, and an anti-IL-23 antibody, or derivative thereof and its use in therapy. The invention also relates to useful anti-IL-6 and anti-IL-23 antibodies.
    Type: Application
    Filed: October 19, 2015
    Publication date: July 7, 2016
    Inventors: Kenneth Grabstein, William Brady, Gordon King, Natalie Winblade Nairn, Kurt David Shanebeck, Paul Heffner Slagle, Kenneth Christopher Thornton, Michael Peter Vanbrunt, Andrea Wang, Hengyu Xu
  • Publication number: 20150104459
    Abstract: The present invention provides compositions, vaccines, and methods for diagnosing, treating, and preventing influenza infection using a combination of antibodies raised against the influenza hemagglutinin and the matrix 2 ectodomain polypeptides.
    Type: Application
    Filed: December 22, 2014
    Publication date: April 16, 2015
    Inventors: Andres G. Grandea, III, Gordon King, Thomas C. Cox, Ole Olsen, Jennifer Mitcham, Matthew Moyle, Phil Hammond
  • Publication number: 20150098948
    Abstract: The present invention provides novel human anti-influenza antibodies and related compositions and methods. These antibodies are used in the diagnosis and treatment of influenza infection.
    Type: Application
    Filed: October 14, 2014
    Publication date: April 9, 2015
    Inventors: Andres G. Grandea, III, Gordon King, Thomas C. Cox, Ole Olsen, Jennifer Mitcham, Matthew Moyle, Phil Hammond
  • Patent number: 8974788
    Abstract: The present invention provides compositions, vaccines, and methods for diagnosing, treating, and preventing influenza infection using a combination of antibodies raised against the influenza hemagglutinin and the matrix 2 ectodomain polypeptides.
    Type: Grant
    Filed: August 12, 2010
    Date of Patent: March 10, 2015
    Assignee: Theraclone Sciences, Inc.
    Inventors: Andres G. Grandea, III, Gordon King, Thomas C. Cox, Ole Olsen, Jennifer Mitcham, Matthew Moyle, Phil Hammond
  • Patent number: 8916160
    Abstract: The present invention provides compositions, vaccines, and methods for diagnosing, treating, and preventing influenza infection using a combination of antibodies raised against the influenza hemagglutinin and the matrix 2 ectodomain polypeptides.
    Type: Grant
    Filed: February 14, 2012
    Date of Patent: December 23, 2014
    Assignee: Theraclone Sciences, Inc.
    Inventors: Andres G. Grandea, III, Gordon King, Thomas C. Cox, Ole Olsen, Jennifer Mitcham, Matthew Moyle, Phil Hammond
  • Publication number: 20140363441
    Abstract: The present invention provides novel human anti-influenza antibodies and related compositions and methods. These antibodies are used in the diagnosis and treatment of influenza infection.
    Type: Application
    Filed: April 18, 2014
    Publication date: December 11, 2014
    Inventors: Andres G. Grandea, III, Gordon King, Thomas C. Cox, Ole Olsen, Jennifer Mitcham, Matthew Moyle, Phil Hammond
  • Patent number: 8858948
    Abstract: The present invention provides novel human anti-influenza antibodies and related compositions and methods. These antibodies are used in the diagnosis and treatment of influenza infection.
    Type: Grant
    Filed: May 20, 2010
    Date of Patent: October 14, 2014
    Assignee: Theraclone Sciences, Inc.
    Inventors: Andres G. Grandea, III, Gordon King, Thomas C. Cox, Ole Olsen, Jennifer Mitcham, Matthew Moyle, Phil Hammond
  • Publication number: 20140135480
    Abstract: The present invention provides novel human anti-influenza antibodies and related compositions and methods. These antibodies are used in the diagnosis and treatment of influenza infection.
    Type: Application
    Filed: June 10, 2013
    Publication date: May 15, 2014
    Applicant: THERACLONE SCIENCES, INC.
    Inventors: Andres G. Grandea, III, Gordon King, Thomas C. Cox, Ole Olsen, Jennifer Mitcham, Matthew Moyle
  • Publication number: 20140127209
    Abstract: The invention relates inter alia to a bivalent, bispecific construct comprising an anti-IL-6 antibody, or derivative thereof, and an anti-IL-23 antibody, or derivative thereof and its use in therapy. The invention also relates to useful anti-IL-6 antibodies and anti-IL-23 antibodies.
    Type: Application
    Filed: March 8, 2013
    Publication date: May 8, 2014
    Inventors: Kenneth GRABSTEIN, William BRADY, Gordon KING, Natalie Winblade NAIRN, Kurt David SHANEBECK, Paul Heffner SLAGLE, Kenneth Christopher THORNTON, Michael Peter VANBRUNT, Andrea WANG, Hengyu XU
  • Patent number: 8460671
    Abstract: The present invention provides novel human anti-influenza antibodies and related compositions and methods. These antibodies are used in the diagnosis and treatment of influenza infection.
    Type: Grant
    Filed: August 23, 2011
    Date of Patent: June 11, 2013
    Assignee: Theraclone Sciences, Inc.
    Inventors: Andres Grandea, III, Gordon King, Thomas Cox, Ole Olsen, Jennifer Mitcham, Matthew Moyle
  • Publication number: 20120315277
    Abstract: The present invention provides novel human anti-influenza antibodies and related compositions and methods. These antibodies are used in the diagnosis and treatment of influenza infection.
    Type: Application
    Filed: March 13, 2012
    Publication date: December 13, 2012
    Applicant: Theraclone Sciences, Inc.
    Inventors: Andres G. Grandea, III, Gordon King, Thomas C. Cox, Ole Olsen, Jennifer Mitcham, Matthew Moyle, Phil Hammond
  • Publication number: 20120207760
    Abstract: The present invention provides compositions, vaccines, and methods for diagnosing, treating, and preventing influenza infection using a combination of antibodies raised against the influenza hemagglutinin and the matrix 2 ectodomain polypeptides.
    Type: Application
    Filed: February 14, 2012
    Publication date: August 16, 2012
    Applicant: Theraclone Sciences, Inc.
    Inventors: Andres G. Grandea, III, Gordon King, Thomas C. Cox, Ole Olsen, Jennifer Mitcham, Matthew Moyle, Phil Hammond
  • Publication number: 20120171218
    Abstract: The present invention provides novel human anti-influenza antibodies and related compositions and methods. These antibodies are used in the diagnosis and treatment of influenza infection.
    Type: Application
    Filed: August 23, 2011
    Publication date: July 5, 2012
    Applicant: Theraclone Sciences, Inc.
    Inventors: Andres Grandea, III, Gordon King, Thomas Cox, Ole Olsen, Jennifer Mitcham, Matthew Moyle
  • Publication number: 20120121603
    Abstract: The present invention provides novel human anti-influenza antibodies and related compositions and methods. These antibodies are used in the diagnosis and treatment of influenza infection.
    Type: Application
    Filed: May 20, 2010
    Publication date: May 17, 2012
    Applicant: Theraclone Sciences, Inc.
    Inventors: Andres G. Grandea, III, Gordon King, Thomas c. Cox, Ole Olsen, Jennifer Mitcham, Matthew Moyle, Phil Hammond
  • Patent number: 8114402
    Abstract: The present invention provides novel human anti-influenza antibodies and related compositions and methods. These antibodies are used in the diagnosis and treatment of influenza infection.
    Type: Grant
    Filed: March 17, 2010
    Date of Patent: February 14, 2012
    Assignee: Theraclone Sciences, Inc.
    Inventors: Andres Grandea, III, Gordon King, Thomas Cox, Ole Olsen, Jennifer Mitcham, Matthew Moyle
  • Patent number: 8057796
    Abstract: The present invention provides novel human anti-influenza antibodies and related compositions and methods. These antibodies are used in the diagnosis and treatment of influenza infection.
    Type: Grant
    Filed: November 12, 2008
    Date of Patent: November 15, 2011
    Assignee: Theraclone Sciences, Inc.
    Inventors: Andres Grandea, III, Gordon King, Thomas Cox, Ole Olsen, Jennifer Mitcham, Matthew Moyle